A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment

NCT ID: NCT00772733

Last Updated: 2011-02-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

936 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-10-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to ensure the quality of the COPD treatment in primary care by implementing planned follow-up visits, where the disease condition is evaluated and optimised in accordance with the national COPD recommendations. If relevant the general practitioner (GP) will refer patients to COPD rehabilitation conducted by relevant municipality rehabilitation teams. Secondarily the purpose is to improve collaboration and communication between the local hospital pulmonologist, GPs and the municipality rehabilitation team

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD Chronic Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* COPD diagnose, verified by spirometry
* Having given informed consent

Exclusion Criteria

\-
Minimum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AstraZeneca Pharmaceuticals

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael Skov Jensen, MD

Role: STUDY_CHAIR

Region Hospital Viborg, DK

Tina Brandt Sorensen, MD

Role: STUDY_CHAIR

Region Hospital Horsens, DK

Ove Grann

Role: PRINCIPAL_INVESTIGATOR

Aalborg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Aarhus, Arhus, Denmark

Site Status

Research Site

Bjerringbro, Viborg, Denmark

Site Status

Research Site

Møldrup, Viborg, Denmark

Site Status

Research Site

Skals, Viborg, Denmark

Site Status

Research Site

Aalborg, , Denmark

Site Status

Research Site

Klarup, , Denmark

Site Status

Research Site

Skive, , Denmark

Site Status

Research Site

Spøttrup, , Denmark

Site Status

Research Site

Stoholm, , Denmark

Site Status

Research Site

Viborg, , Denmark

Site Status

Research Site

Ørum, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-RDK-DUM-2007/1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.